Распространенность первичной лекарственной резистентности вируса гепатита В

03.02.2011

Литература

  1. Шахгильдян И.В., Михайлов М.И., Онищенко Г.Г. Парентеральные вирусные гепатиты (эпидемиология, диагностика, профилактика). - М.: ВУНМЦ Росздрава, 2003. С. 22 - 27.
  2. Bozdayi A., Eyigun C., Turkyilmaz A. et al. A novel pattern (sW195a) in surface gene of HBV DNA due to YSDD (L180M plus M204S) mutation selected during lamivudine therapy and successful treatment with adefovir dipivoxil // J. Clin. Virol. 2004. V. 31. R. 76, 77.
  3. Bozdayi A.M., Uzunalimog O., Turkyilmaz A.R. et al. YSDD: a novel mutation in HBV DNA polymerase confers clinical resistance to lamivu-dine // J. Viral Hepatitis. 2003. V. 10. R. 256 - 265.
  4. Carman W.F. The clinical significance of surface antigen variants of hepatitis B virus // J. Viral. Hepat. 1997. V. 4. R. 11 - 20.
  5. Chaudhuri V., Tayal R., Nayak B. et al. Occult hepatitis B virus infection in chronic liver disease: full-length genome and analysis of mutant surface promoter // Gastroenterol. 2004. V. 127. R. 1356 - 1371.
  6. Colonno R., Rose R., Baldick C. Entecavir resistance is rare in nucle-oside naive patients with hepatitis B // Hepatol. 2006. V. 44. R. 1656 - 1665.
  7. Guenther S., Fischer L., Rult I. et al. Naturally occurring variants of hepatitis B virus // Adv. Vir. Res. 1999. V. 52. R. 25 - 37.
  8. Guenther S., Nelson M., Lutz T. et al. Combination of tenofovir and lami-vudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfection // AIDS. 2006. V. 20. R. 1951 - 1954.
  9. Hie-Won H., Dixon J. A review of the one-year incidence of resistance to lamivudine in the treatment of chronic hepatitis B // Hepatol. Int. 2008. V. 2. R. 440 - 456.
  10. Margeridon-Thermet S., Shulman S., Ahmed A. et al. Ultra-deep py-rosequencing of hepatitis B virus quasispecies from nucleoside and nucleotide reverse-transcriptase inhibitor (NRTI)-treated patients and NRTI-naive patients // J. Infect. Dis. 2009. V. 199. R. 1275 - 1285.
  11. Ras S.D., Fries E., Robert A. Development of a quantitative real-time detection assay for hepatitis B virus DNA and comparison with two commercial assays // J. Clin. Microbiol. 2000. V. 38. R. 2897 - 2901.
  12. Younger M., Bathgate A. Review article: nucleoside analogue for the treatment of chronic hepatitis B // Aliment. Rharmacol. Ther. 2004. V. 20. R. 1211 - 1230.
  13. Xu X.-W., Chen Y.-G. Current therapy with nucleoside/nucleotide analogs for patients with chronic hepatitis B // Hepatobiliary Rancreat. Dis. Int. 2006. V. 5. R. 350 - 359.